Eagle Pharmaceuticals Inc
NASDAQ:EGRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Eagle Pharmaceuticals Inc
NASDAQ:EGRX
|
US |
|
P
|
Profithol SA
MAD:SPH
|
ES |
|
Zahrat Al Waha for Trading Company CJSC
SAU:3007
|
SA |
|
Friulchem SpA
MIL:FCM
|
IT |
|
D
|
Dx & Vx Co Ltd
KOSDAQ:180400
|
KR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EGRX's stock price target?
Not Available
EGRX doesn't have any price targets made by Wall Street professionals.
What is Eagle Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
-10%
For the last 8 years the
compound annual growth rate for
Eagle Pharmaceuticals Inc's revenue is
42%.
The projected
CAGR
for the next 3 years is
-10%.
What is Eagle Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
-21%
The
compound annual growth rate
of Eagle Pharmaceuticals Inc's operating income for the next 3 years is
-21%.
What is Eagle Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
4%
The
compound annual growth rate
of Eagle Pharmaceuticals Inc's net income for the next 3 years is
4%.
